These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 315034)

  • 21. Differences in in vitro incorporation of tritiated deoxycytidine and tritiated thymidine into human lymphocytes.
    Akasaka TL; Olds-Arroyo L; Miller JJ
    Experientia; 1979 May; 35(5):673-4. PubMed ID: 312740
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of lymphocytes which inhibit proliferation of human T cells exposed to lymphocyte-derived mitogenic factors.
    Blomgren H
    Int Arch Allergy Appl Immunol; 1979; 59(2):192-8. PubMed ID: 312769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Subpopulations of peripheral blood T-lymphocytes in patients with chronic glomerulonephritis].
    Rakitianskaia IA
    Urol Nefrol (Mosk); 1989; (4):55-8. PubMed ID: 2800080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy.
    Mandreoli M; Beltrandi E; Casadei-Maldini M; Mancini R; Zucchelli A; Zucchelli P
    Clin Nephrol; 1992 Apr; 37(4):177-82. PubMed ID: 1582055
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cellular immunity in idiopathic nephrotic syndrome with minimal glomerular lesions and focal and segmental hyalinosis in children].
    Batellier H; Dechelette E; Bensa JC; Bost M
    Arch Fr Pediatr; 1983 Mar; 40(3):149-55. PubMed ID: 6603829
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Active E rosette formation by human lymphoblasts.
    Semenzato G; Amadori G; Sarasin P; Gasparotto G
    Immunology; 1978 Apr; 34(4):721-4. PubMed ID: 309851
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Defective T-lymphocyte colony formation in patients with lupus nephritis.
    Matsumoto K; Hatano M
    J Clin Lab Immunol; 1987 Nov; 24(3):151-4. PubMed ID: 3501475
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Evaluation of immune reactivity in relation to the therapeutic and clinical response of the nephrotic syndrome in children].
    Tazzari R; Beltrandi E; Rossini R
    Minerva Nefrol; 1981; 28(3):209-13. PubMed ID: 6977107
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of interleukin-15 on vascular permeability factor release by peripheral blood mononuclear cells in normal subjects and in patients with minimal-change nephrotic syndrome.
    Matsumoto K; Ohi H; Kanmatsuse K
    Nephron; 1999; 82(1):32-8. PubMed ID: 10224482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional properties of the 50 kd protein associated with the E-receptor on human T lymphocytes: suppression of IL 2 production by anti-p50 monoclonal antibodies.
    Tadmori W; Reed JC; Nowell PC; Kamoun M
    J Immunol; 1985 Mar; 134(3):1709-16. PubMed ID: 2981919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of pentoxifylline on E-rosette formation and on the mitogenic response of human mononuclear cells.
    Bessler H; Gilgal R; Zahavi I; Djaldetti M
    Biomed Pharmacother; 1987; 41(8):439-41. PubMed ID: 3502534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunological studies of human endometrium--suppression of lymphocyte mitogenesis by endometrial extract.
    Fujisaki S; Maeyama M
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1105-10. PubMed ID: 3746028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive activity of serum lipoproteins from patients with idiopathic nephrotic syndrome.
    Inoue K; Yamashita U; Yamashita F
    Jpn J Exp Med; 1984 Apr; 54(2):73-80. PubMed ID: 6471527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cyclosporin A does not inhibit the PHA-stimulated increase in intracellular Ca2+ concentration but inhibits the increase in E-rosette receptor (CD2) expression and appearance of interleukin-2 receptors (CD25).
    Redelman D
    Cytometry; 1988 Mar; 9(2):156-63. PubMed ID: 2896111
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PHA-induced soluble factor(s) can activate B-cells from patients with chronic lymphatic leukaemia.
    Robert KH
    Clin Exp Immunol; 1979 Sep; 37(3):517-22. PubMed ID: 315847
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of the age-related refractoriness of T-lymphocyte reactivity in humans.
    Bátory G; Onody C; Petrányi GG
    Mech Ageing Dev; 1981 Apr; 15(4):337-47. PubMed ID: 7017296
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of interleukin 2 receptor acquisition by monoclonal antibodies recognizing the 50 KD protein associated with the sheep erythrocyte receptor on human T lymphocytes.
    Reed JC; Tadmori W; Kamoun M; Koretzky G; Nowell PC
    J Immunol; 1985 Mar; 134(3):1631-9. PubMed ID: 2981917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological profile in children with minimal change nephrotic syndrome.
    Gupta S; Yuceoglu AM
    Acta Paediatr Scand; 1985 Sep; 74(5):726-32. PubMed ID: 2931943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of shenqiwan on immunological function in the nephrotic syndrome of chronic glomerulonephritis patients].
    Wang J; Zhang DS
    Zhong Xi Yi Jie He Za Zhi; 1987 Dec; 7(12):731-3, 709. PubMed ID: 3502398
    [No Abstract]   [Full Text] [Related]  

  • 40. Effect of dipyridamole upon thymidine incorporation and capping in human lymphocytes.
    Brohée D; Piro P; Kennes B; Nève P
    Int J Immunopharmacol; 1986; 8(8):925-9. PubMed ID: 3804535
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.